New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
09:06 EDTMACKMerrimack announces positive clinical data for agent to treat breast cancer
Merrimack announced Phase I clinical trial results for MM-302, the company's agent for the treatment of advanced HER2 positive breast cancer. The findings demonstrated preliminary safety and tolerability.
News For MACK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
15:17 EDTMACKMerrimack to host analyst day
Subscribe for More Information
December 12, 2014
08:05 EDTMACKMerrimack presents research on MM-398, MM-302, MM-121
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use